MAPT and Alzheimer disease: Using a monoclonal anti-tau antibody coated gold nanomaterial for the ultrasensitive and selective detection of tau protein AD biomarker at a 1 pg/mL level, a two-photon Rayleigh scattering (TPRS) assay has been developed.